Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients? Tomao Federica et al. Gynecologic oncology 2019 154(1) 138-143

Main|Search|PHGKB




Last Posted: Aug 29, 2019

---

• Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
  Tomao Federica et al. Gynecologic oncology 2019 154(1) 138-143
• New BRCA recommendations: What primary care doctors must know,
  by Kevin B. O?Reilly, AMA, August 22, 2019
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
  Nelson Heidi D et al. JAMA 2019 322(7) 666-685
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
  et al. JAMA 2019 322(7) 652-665
• US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
  Newman Lisa et al. JAMA surgery 2019 Aug
• USPSTF Recommendation Expands Cancer Screening Pool, Concerns Still Remain
  KL Kahl, Cure, August 26, 2019
• New USPSTF BRCA Recommendations Still Fall Short,
  by Brielle Benyon, Oncology Nursing News, August 24, 2019
• Should I Be Tested for BRCA Mutations?
  Jin Jill et al. JAMA 2019 322(7) 702
• Cancer Patient Says Question Could Save Lives: 'Do You Have Eastern European Jewish Ancestry?'
  C Goldberg, WBUR, August 21, 2019
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer US Preventive Services Task Force Recommendation Statement
  USPSTF, JAMA, August 20, 2019

more